SCHEMBL9164476

SCHEMBL9164476

Cc1ccc(S(=O)(=O)Nc2c(C(C)C)cccc2C(C)C)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 2/20 0.67
GAA P10253 3/20 0.55
ALDH1A1 P00352 2/20 0.55
LMNA P02545 2/20 0.55
CA1 P00915 3/20 0.54
CA2 P00918 3/20 0.54
CA9 Q16790 2/20 0.54
FFAR4 Q5NUL3 1/20 0.54
CA12 O43570 1/20 0.54
USP2 O75604 1/20 0.51
POLB P06746 1/20 0.51
MAPT P10636 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
NOD2 Q9HC29 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
KEAP1 Q14145 1/20 0.51
NFE2L2 Q16236 1/20 0.51
CYTH2 Q99418 1/20 0.50
MEN1 O00255 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5160629 0.92 NLRP3 (0.62) NLRP3GAAALDH1A1LMNACA1
SCHEMBL12462804 0.85 KMT2A (0.53) NLRP3ALDH1A1LMNACA1CA2
SCHEMBL2434886 0.82 GAA (0.55) NLRP3GAAALDH1A1LMNACA1
SCHEMBL9059808 0.81 NLRP3 (0.47) NLRP3GAAALDH1A1LMNAPOLB
SCHEMBL31681252 0.80 FFAR4 (0.57) NLRP3ALDH1A1LMNACA2FFAR4
SCHEMBL2433650 0.79 ALDH1A1 (0.51) NLRP3GAAALDH1A1LMNACA1
SCHEMBL10884844 0.78 TSHR (0.73) GAAALDH1A1LMNACA1CA2
SCHEMBL25196007 0.77 GBA1 (0.64) NLRP3GAAALDH1A1LMNACA1
SCHEMBL8962523 0.77 NLRP3 (0.50) NLRP3ALDH1A1LMNACA9CA12
SCHEMBL27182555 0.77 L3MBTL1 (0.46) NLRP3LMNAPOLBL3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5442060-A Treating hyperlipemia, atherosclerosis MITSUBISHI KASEI CORPORATION (JP) 1995-08-15 US disclosed
EP-0591830-A1 Carboxamide and urea derivatives having ACAT-inhibiting activityM Mitsubishi Chemical Corporation (JP) 1994-04-13 EP disclosed